TY - JOUR
T1 - Trending of impedance-monitored cardiac variables
T2 - Method and statistical power analysis of 100 control studies in a pediatric intensive care unit
AU - Mickell, J. J.
AU - Lucking, S. E.
AU - Chaten, F. C.
AU - Young, E. S.
PY - 1990/1/1
Y1 - 1990/1/1
N2 - The NCCOM3-R6 monitor continuously monitors cardiac output and five other cardiovascular variables from the thoracic electrical bioimpedance signal. We averaged data over 5-min intervals for 130 min in 100 control studies in 40 pediatric ICU patients, age 0.04 to 20.39 yr (median 1.39) and weighing 2.0 to 59.5 kg (median 8.8). For individual studies, 99% of the 5-min averages of cardiac output fell within ± 44% of the baseline cardiac output for that study. Normal ranges were somewhat narrower for the other five variables. When we averaged data for 100 studies, 5-min interval observations for each variable did not deviate from baseline over a 2-h period (p > .70). With a sample size of 100 studies, we could detect a change in cardiac output of ± 5% at the p < .005 level with a power of 0.95. We conclude that with a sufficiently large sample size, studies employing the NCCOM3 can detect clinically significant cardiovascular changes due to pharmacologic or procedural stressors.
AB - The NCCOM3-R6 monitor continuously monitors cardiac output and five other cardiovascular variables from the thoracic electrical bioimpedance signal. We averaged data over 5-min intervals for 130 min in 100 control studies in 40 pediatric ICU patients, age 0.04 to 20.39 yr (median 1.39) and weighing 2.0 to 59.5 kg (median 8.8). For individual studies, 99% of the 5-min averages of cardiac output fell within ± 44% of the baseline cardiac output for that study. Normal ranges were somewhat narrower for the other five variables. When we averaged data for 100 studies, 5-min interval observations for each variable did not deviate from baseline over a 2-h period (p > .70). With a sample size of 100 studies, we could detect a change in cardiac output of ± 5% at the p < .005 level with a power of 0.95. We conclude that with a sufficiently large sample size, studies employing the NCCOM3 can detect clinically significant cardiovascular changes due to pharmacologic or procedural stressors.
UR - http://www.scopus.com/inward/record.url?scp=0025330258&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025330258&partnerID=8YFLogxK
U2 - 10.1097/00003246-199006000-00014
DO - 10.1097/00003246-199006000-00014
M3 - Article
C2 - 2344756
AN - SCOPUS:0025330258
SN - 0090-3493
VL - 18
SP - 645
EP - 650
JO - Critical care medicine
JF - Critical care medicine
IS - 6
ER -